HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation.

AuthorsDragana Milojkovic, Amr Ibrahim, Alistair Reid, Letizia Foroni, Jane Apperley, David Marin
JournalHaematologica (Haematologica) Vol. 97 Issue 3 Pg. 473-4 (Mar 2012) ISSN: 1592-8721 [Electronic] Italy
PMID22133777 (Publication Type: Case Reports, Letter)
Chemical References
  • Pyrimidines
  • Thiazoles
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Vidarabine
  • fludarabine
  • Dasatinib
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Blast Crisis (drug therapy)
  • Cytarabine (administration & dosage)
  • Dasatinib
  • Female
  • Granulocyte Colony-Stimulating Factor (administration & dosage)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, pathology)
  • Male
  • Middle Aged
  • Pyrimidines (administration & dosage)
  • Thiazoles (administration & dosage)
  • Treatment Outcome
  • Vidarabine (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: